Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy

Context: The correlation between aggressive prostate cancer and obesity mainly based on body mass index (BMI) and pathology after surgery remains controversial. Aims: The aim of the study was to correlate BMI, visceral adiposity index (VAI), and the plasmatic levels of leptin, adiponectin, and matri...

Full description

Bibliographic Details
Main Authors: Vincenzo Serretta, Alberto Abrate, Simone Siracusano, Cristina Scalici Gesolfo, Marco Vella, Fabrizio Di Maida, Antonina Cangemi, Giuseppe Cicero, Elisabetta Barresi, Chiara Sanfilippo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Urology Annals
Subjects:
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2018;volume=10;issue=3;spage=280;epage=286;aulast=Serretta
id doaj-5b1dc3369ae14e5eaa54cd3aa4673cd5
record_format Article
spelling doaj-5b1dc3369ae14e5eaa54cd3aa4673cd52020-11-25T02:28:17ZengWolters Kluwer Medknow PublicationsUrology Annals0974-77960974-78342018-01-0110328028610.4103/UA.UA_188_17Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsyVincenzo SerrettaAlberto AbrateSimone SiracusanoCristina Scalici GesolfoMarco VellaFabrizio Di MaidaAntonina CangemiGiuseppe CiceroElisabetta BarresiChiara SanfilippoContext: The correlation between aggressive prostate cancer and obesity mainly based on body mass index (BMI) and pathology after surgery remains controversial. Aims: The aim of the study was to correlate BMI, visceral adiposity index (VAI), and the plasmatic levels of leptin, adiponectin, and matrix metalloproteinase-3 (MMP-3), and biomarkers of adipose tissue function, with the detection of Gleason patterns 4 and 5 at biopsy. Subjects and Methods: Consecutive patients with prostate cancer at 12-core transrectal biopsy were enrolled. BMI, waist circumference (WC), blood samples to evaluate the plasmatic levels of triglycerides (TG) and high-density lipoproteins (HDL), adiponectin, leptin, and MMP-3 were obtained immediately before biopsy. The VAI was calculated according to the formula: WC/(39.68 + [1.88 × BMI]) × TG/1.03 × 1.31/HDL. Results: One hundred and forty-nine patients were entered. The median PSA, BMI, and VAI were 10.0 ng/ml, 27.6 kg/m2, and 4.6, respectively. Gleason patterns 4 or 5 were detected in 68 (45.6%) patients; in 15 (41.7%), 31 (44.9%), and 22 (50.0%) among normal weight, overweight, and obese patients, respectively (P = 0.55). The statistical analysis did not show any significant correlation between BMI, VAI, the plasmatic levels of leptin, adiponectin, MMP-3, and the detection of Gleason patterns 4 and 5 at biopsy. A statistically significant association emerged with older age (P = 0.017) and higher PSA values (P = 0.02). Conclusion: We did not find any association between BMI, VAI, the plasmatic levels of adiponectin, leptin, and MMP-3 and the detection of Gleason patterns 4 and 5 at prostate biopsy.http://www.urologyannals.com/article.asp?issn=0974-7796;year=2018;volume=10;issue=3;spage=280;epage=286;aulast=SerrettaAdiponectinbody mass indexGleason patternleptinmatrix metalloproteinase-3obesityprostate cancervisceral adiposity index
collection DOAJ
language English
format Article
sources DOAJ
author Vincenzo Serretta
Alberto Abrate
Simone Siracusano
Cristina Scalici Gesolfo
Marco Vella
Fabrizio Di Maida
Antonina Cangemi
Giuseppe Cicero
Elisabetta Barresi
Chiara Sanfilippo
spellingShingle Vincenzo Serretta
Alberto Abrate
Simone Siracusano
Cristina Scalici Gesolfo
Marco Vella
Fabrizio Di Maida
Antonina Cangemi
Giuseppe Cicero
Elisabetta Barresi
Chiara Sanfilippo
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
Urology Annals
Adiponectin
body mass index
Gleason pattern
leptin
matrix metalloproteinase-3
obesity
prostate cancer
visceral adiposity index
author_facet Vincenzo Serretta
Alberto Abrate
Simone Siracusano
Cristina Scalici Gesolfo
Marco Vella
Fabrizio Di Maida
Antonina Cangemi
Giuseppe Cicero
Elisabetta Barresi
Chiara Sanfilippo
author_sort Vincenzo Serretta
title Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
title_short Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
title_full Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
title_fullStr Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
title_full_unstemmed Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
title_sort clinical and biochemical markers of visceral adipose tissue activity: body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. correlation with gleason patterns 4 and 5 at prostate biopsy
publisher Wolters Kluwer Medknow Publications
series Urology Annals
issn 0974-7796
0974-7834
publishDate 2018-01-01
description Context: The correlation between aggressive prostate cancer and obesity mainly based on body mass index (BMI) and pathology after surgery remains controversial. Aims: The aim of the study was to correlate BMI, visceral adiposity index (VAI), and the plasmatic levels of leptin, adiponectin, and matrix metalloproteinase-3 (MMP-3), and biomarkers of adipose tissue function, with the detection of Gleason patterns 4 and 5 at biopsy. Subjects and Methods: Consecutive patients with prostate cancer at 12-core transrectal biopsy were enrolled. BMI, waist circumference (WC), blood samples to evaluate the plasmatic levels of triglycerides (TG) and high-density lipoproteins (HDL), adiponectin, leptin, and MMP-3 were obtained immediately before biopsy. The VAI was calculated according to the formula: WC/(39.68 + [1.88 × BMI]) × TG/1.03 × 1.31/HDL. Results: One hundred and forty-nine patients were entered. The median PSA, BMI, and VAI were 10.0 ng/ml, 27.6 kg/m2, and 4.6, respectively. Gleason patterns 4 or 5 were detected in 68 (45.6%) patients; in 15 (41.7%), 31 (44.9%), and 22 (50.0%) among normal weight, overweight, and obese patients, respectively (P = 0.55). The statistical analysis did not show any significant correlation between BMI, VAI, the plasmatic levels of leptin, adiponectin, MMP-3, and the detection of Gleason patterns 4 and 5 at biopsy. A statistically significant association emerged with older age (P = 0.017) and higher PSA values (P = 0.02). Conclusion: We did not find any association between BMI, VAI, the plasmatic levels of adiponectin, leptin, and MMP-3 and the detection of Gleason patterns 4 and 5 at prostate biopsy.
topic Adiponectin
body mass index
Gleason pattern
leptin
matrix metalloproteinase-3
obesity
prostate cancer
visceral adiposity index
url http://www.urologyannals.com/article.asp?issn=0974-7796;year=2018;volume=10;issue=3;spage=280;epage=286;aulast=Serretta
work_keys_str_mv AT vincenzoserretta clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT albertoabrate clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT simonesiracusano clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT cristinascalicigesolfo clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT marcovella clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT fabriziodimaida clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT antoninacangemi clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT giuseppecicero clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT elisabettabarresi clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
AT chiarasanfilippo clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy
_version_ 1724839321867911168